Telix Pharmaceuticals Ltd has released a press release.
Illuccix Approved in the United Kingdom
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix Completes Acquisition of Tx Assets, Biologics Platform
- Telix Completes Acquisition of RLS (USA) Inc
- Illuccix Receives European Approval
- Telix JP Morgan Healthcare Conference 2025 Presentation
- Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
Later from Telix Pharmaceuticals
- Appendix 4E and 2024 Annual Report
- 2024 Full Year Results Announcement
- 2024 Full Year Results Presentation
- Telix Announces Change in Reporting Currency to USD
- FDA accepts BLA and grants priority review for Zircaix
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals